Indefinite Delivery Contract 36C25223D0046
Award Date
3/1/23
Last Date to Order
2/29/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
RLS (USA) Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
RLS USA Inc. was awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide radiopharmaceutical products. The potential value of the contract is $1,162,500. No set-aside designation was applied. Under the contract, RLS USA Inc. received two delivery orders to date for radiopharmaceutical supplies. The first delivery order, valued at $244,564.67, was awarded on August 2, 2022 for a performance...
This Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 5 (VISN 5), a component of the U.S. Department of Veterans Affairs (VA), to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $2,162,919.87 and a period of performance extending to March 31, 2030. The contract is for the provision of radiopharmaceuticals, which are critical for nuclear medicine diagnostic services at VA medical centers. RLS (USA)...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to RLS USA Inc. to provide non-PET radiopharmaceuticals in support of nuclear medicine services. The contract established a potential value of $733,420.11 over its period of performance from October 2021 through September 2024. Delivery orders issued against this contract included awards of $251,729.90, $244,402.04, and $650,585.28 to RLS USA Inc. for...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 21 has awarded an Indefinite Delivery Contract (IDC) worth up to $1,200,000 to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to VA medical centers and military treatment facilities. The initial task order under this IDC is valued at $179,605.38 and covers the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, to provide radiopharmaceuticals and related supplies to the VA Northern California Health Care System (VANCHCS). The contract has a ceiling value of $2,500,000 and a performance period through March 31, 2030. Under this IDC, RLS (USA) Inc. will deliver radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18,...
This federal contract IDV award is a single-award indefinite delivery contract between the U.S. Department of Veterans Affairs (VA) and the prime contractor RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a total ceiling value of $249,500 and a performance period ending on March 31, 2025. Under this IDV, RLS (USA) Inc. will supply a variety of non-PET radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers and military...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract has a ceiling value of $4,998,603.38 and a performance period through September 17, 2029. The contract is for the provision of critical radiopharmaceuticals used in nuclear medicine diagnostic services at VA medical centers and military treatment facilities, including gallium-67,...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the delivery of non-positron emission tomography (non-PET) radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. The contract has a performance period from April 1, 2025, to March 31, 2026, with a ceiling value of $425,725.07. RLS (USA) Inc. is an experienced federal...
The Defense Health Agency awarded RLS USA Inc. a single award indefinite delivery contract for radiopharmaceuticals with a potential value of $1,914,116.40 over five years. No set-aside provisions were applied. Under this vehicle, RLS USA Inc. received a firm fixed price delivery order for $299,975.67 to supply unspecified radiopharmaceutical products to the Defense Health Agency from their Tampa, Florida facility between November 2022 through September 2023. Additionally, a $64,238.93 order was...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded an indefinite delivery contract to Medi-Physics, Inc. to provide radiopharmaceuticals in support of nuclear medicine services. No set-aside provisions were applied. The contract includes a potential value of $633,955.36 over its period of performance from March 1, 2020 through February 28, 2023. Delivery orders issued against the contract include $214,344.50 awarded on March 1, 2022...